Erythrasma in Khuzestan Province: An Eleven-year Study (2003–2014)

Document Type : Original Article

Authors

1 Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran and Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran and Iran Zamin Medical Diagnostic Laboratory, Ahvaz, Iran.

2 Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran and Iran Zamin Medical Diagnostic Laboratory, Ahvaz, Iran

3 Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran and Nutrition and Metabolic Disease Research Center, Clinical Sciences Research Institute ،Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

4 Student Research Committee, Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

10.61186/jsmj.2023.363219.2952

Abstract

Background and Objectives This study aimed to determine the frequency of erythrasma, a superficial mycosis in outpatients referring to Iran-Zamin Medical Diagnostic Laboratory in Ahvaz, the provincial capital of Khuzestan, over eleven years (2003-2014). Subjects and Methods The investigation was carried out by direct testing on patients. Shaved skin from the infected areas, including the inguinal, axillary, interdigital space, and inframammary, was tested directly using 20% potassium hydroxide (KOH). Samples were stained with 2.5% methylene blue. Results A total of 25,643 patients were referred to Iran-Zemin Medical Diagnostic Laboratory from various parts of Khuzestan province. Among this population, 942 (3.67%) subjects were suffering from erythrasma, with 625 (66.4%) males and 317 (33.6%) females, ranging in age from 1 to 67 years. Erythrasma was found in 942 of the suspected patients. Therefore, 715 inguinal areas (75.9%), 133 axillary areas (14.1%), 58 interdigital regions (6.2%), and 36 inframammary regions (3.8%) were all positive for erythrasma disease. As a result, the results of the present study can be useful in providing accurate information on the prevalence of erythrasma in Khuzestan province. Regarding this, management, control, and monitoring of the spread of this disease are essential. Conclusion The findings of the present study confirmed the frequency of erythrasma in the region and should be considered in the differential diagnosis. The most commonly affected part was the groin and its frequency was higher in males.

Keywords

Main Subjects


[1] Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's principles and practice of infectious diseases E-book: Elsevier Health Sciences. 2019.[Link]
[2] Penton PK, Tyagi E, Humrighouse BW, McQuiston JR. Complete genome sequence of Corynebacterium minutissimum, an opportunistic pathogen and the causative agent of erythrasma. Genome Announcements. 2015;3(2):e00139-15. [DOI:10.1128/genomeA.00139-15] [PMID]
[3] Inci M, Serarslan G, Ozer B, Inan M, Evirgen O, Erkaslan Alagoz G, et al. The prevalence of interdigital erythrasma in the southern region of Turkey. J Eur Acad Dermatol Venereol. 2012;26(11):1372-6. [DOI:10.1111/j.1468-3083.2011.04293.x] [PMID]
[4] Climate and Average Weather Year Round in Ahvaz Iran. [Link]
[5] Koumantaki-Mathioudaki E. Erythrasma. European Handbook of Dermatological Treatments: Springer. 2000:189-91. [Link]
[6] Somerville DA. Erythrasma in normal young adults. J Med Microbiol. 1970;3(1):57-64. [DOI:10.1099/00222615-3-1-57] [PMID]
[7] Holdiness MR. Management of cutaneous erythrasma. Drugs. 2002;62(8):1131-41. [DOI:10.2165/00003495-200262080-00002] [PMID]
[8] Blaise G, Nikkels AF, Hermanns‐Lê T, Nikkels‐Tassoudji N, Piérard GE. Corynebacterium‐associated skin infections. Int J Dermatol. 2008;47(9):884-90. [DOI:10.1111/j.1365-4632. 2008.03773.x] [PMID]
[9] Groves JB, Nassereddin A, Freeman AM. Erythrasma. StatPearls [Internet]: StatPearls . 2023. [Link]
[10] Halvaee S, Ghazvini RD, Hashemi SJ, Zibafar E, Yekaninejad S, Geramishoar M, Bakhshi H, Mahmoudi S, Sarvestani HK, Yaghoubi R, Hosseinpour L. Investigation of intertriginous mycotic and pseudomycotic (erythrasma) infections and their causative agents with emphasize on clinical presentations. Iran J Public Health. 2018;47(9):1406. [PMID]
[11] Ramírez-Hobak L, Moreno-Coutiño G, Arenas-Guzmán R, Gorzelewski A, Fernández-Martínez R. [Treatment of interdigital foot Erythrasma with ozonated olive oil (Spanish)]. Rev Med Inst Mex Seguro Soc. 2016;54(4):458-61. [PMID]
[12] Sariguzel FM, Koc AN, Yagmur G, Berk E. Interdigital foot infections: Corynebacterium minutissimum and agents of superficial mycoses. Braz J Microbiol. 2014;45(3):781-4. [DOI:10.1590/s1517-83822014000300003] [PMID]
[13] Barajee M. 2017. The frequency of erythrasma in outpatients in Khuzestan province. 9th International Congress of Laboratory and Clinic. Tehran. [Link]
[14] Salari S, Mousavi SAA, Hadizadeh S, Izadi A. Epidemiology of dermatomycoses in Kerman province, southeast of Iran: a 10-year retrospective study (2004–2014). Microb Pathog. 2017;110:561-7. [DOI:10.1016/j.micpath.2017.07.043] [PMID]
[15] Allen S, Christmas TI, McKinney W, Parr D, Oliver GF. The Auckland skin clinic tinea pedis and erythrasma study. N Z Med J. 1990;103(896):391-3. [PMID]
[16] Sarkany I, Taplin D, Blank H. The etiology and treatment of erythrasma. J Invest Dermatol. 1961;37(4):283-90. [PMID]
[17] Al-Obaidi RMD, Khallaf SA. Clinical study of Erythrasma in diabetic patients. La Prensa Médica Argentina. 2021:152. [DOI:10.47275/0032-745X-320]
[18] Karaca S, Kulac M, Cetinkaya Z, Demirel R. Etiology of foot intertrigo in the district of Afyonkarahisar, Turkey. J Am Podiatr Med Assoc. 2008;98(1):42-4. [PMID]
[19] Morales-Trujillo M, Arenas R, Arroyo S. [Interdigital erythrasma: clinical, epidemiologic, and microbiologic findings(Spanish)]. Actas Dermosifiliogr. 2008;99(6):469-73. [PMID]
[20] Zisova L, Valchev V, Kasabov G. Erythrasma in athletes and football players. Wien Med Wochenschr. 2021;171(1):24-8. [DOI:10.1007/s10354-020-00753-2] [PMID]
[21] Temple DE, Boardman CR. The incidence of erythrasma of the toewebs. Arch Dermatol. 1962;86(4):518-9. [DOI:10.1001/ archderm.1962.01590100132024] [PMID]
[22] Groves JB NA, Freeman AM. Erythrasma Treasure Island (FL): StatPearls Publishing. 2022 [Link]
[23] Edwards L. Vulvar dermatoses: Papulosquamous diseases. Obstetric and Gynecologic Dermatology 3rd ed London: Mosby Elsevier. 2008.
[24] Afshari M. Superficial and Cutaneous Mycoses in Janbasan Dormitories in Tehran. Trauma Monthly. 2000;5(3):189-94.
[25] Janeczek M, Kozel Z, Bhasin R, Tao J, Eilers D, Swan J. High prevalence of erythrasma in patients with inverse psoriasis: a cross-sectional study. J Clin Aesthet Dermatol. 2020;13(3):12-14. [PMID]